These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37501928)

  • 1. Combining conventional ultrasound and ultrasound elastography to predict HER2 status in patients with breast cancer.
    Zhuo X; Lv J; Chen B; Liu J; Luo Y; Liu J; Xie X; Lu J; Zhao N
    Front Physiol; 2023; 14():1188502. PubMed ID: 37501928
    [No Abstract]   [Full Text] [Related]  

  • 2. A Model Combining Conventional Ultrasound Characteristics, Strain Elastography and Clinicopathological Features to Predict Ki-67 Expression in Small Breast Cancer.
    Xing X; Miao H; Wang H; Sun J; Wu C; Wang Y; Zhou X; Wang H
    Ultrason Imaging; 2024 Mar; 46(2):121-129. PubMed ID: 38197383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Model for Predicting Axillary Lymph Node Metastasis in Clinically Node Positive Breast Cancer Based on Peritumoral Ultrasound Radiomics and SHAP Feature Analysis.
    Wang SR; Cao CL; Du TT; Wang JL; Li J; Li WX; Chen M
    J Ultrasound Med; 2024 Sep; 43(9):1611-1625. PubMed ID: 38808580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results.
    Yan M; Yao J; Zhang X; Xu D; Yang C
    Cancer Med; 2024 Feb; 13(3):e6946. PubMed ID: 38234171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A machine learning model based on ultrasound image features to assess the risk of sentinel lymph node metastasis in breast cancer patients: Applications of scikit-learn and SHAP.
    Zhang G; Shi Y; Yin P; Liu F; Fang Y; Li X; Zhang Q; Zhang Z
    Front Oncol; 2022; 12():944569. PubMed ID: 35957890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning radiomics model based on breast ultrasound video to predict HER2 expression status.
    Quan MY; Huang YX; Wang CY; Zhang Q; Chang C; Zhou SC
    Front Endocrinol (Lausanne); 2023; 14():1144812. PubMed ID: 37143737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI model to predict molecular subtypes of breast cancer using Shapley additive explanations interpretability analysis.
    Huang Y; Wang X; Cao Y; Li M; Li L; Chen H; Tang S; Lan X; Jiang F; Zhang J
    Diagn Interv Imaging; 2024 May; 105(5):191-205. PubMed ID: 38272773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional ultrasound and contrast-enhanced ultrasound radiomics in breast cancer and molecular subtype diagnosis.
    Gong X; Li Q; Gu L; Chen C; Liu X; Zhang X; Wang B; Sun C; Yang D; Li L; Wang Y
    Front Oncol; 2023; 13():1158736. PubMed ID: 37287927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.
    Huang Y; Wei L; Hu Y; Shao N; Lin Y; He S; Shi H; Zhang X; Lin Y
    Front Oncol; 2021; 11():706733. PubMed ID: 34490107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An XGBoost Machine Learning Based Model for Predicting Ki-67 Value ≥ 15% in T
    Lu Y; Yang F; Tao Y; An P
    Technol Cancer Res Treat; 2024; 23():15330338241265989. PubMed ID: 39051517
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of ultrasound elastography in detecting small breast tumors.
    Fu LN; Wang Y; Wang Y; Huang YH
    Chin Med J (Engl); 2011 Aug; 124(15):2384-6. PubMed ID: 21933573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma
    Zhu M; Kuang Y; Jiang Z; Liu J; Zhang H; Zhao H; Luo H; Chen Y; Peng Y
    Gland Surg; 2024 Apr; 13(4):512-527. PubMed ID: 38720675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study to compare the diagnostic performance of breast elastography versus conventional breast ultrasound.
    Leong LC; Sim LS; Lee YS; Ng FC; Wan CM; Fook-Chong SM; Jara-Lazaro AR; Tan PH
    Clin Radiol; 2010 Nov; 65(11):887-94. PubMed ID: 20933643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers, pathology, and ultrasound features of invasive breast cancer.
    Huang Z; Chen L; Wang Y; Fu L; Lv R
    Clin Imaging; 2021 Nov; 79():85-93. PubMed ID: 33895560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer.
    Du LW; Liu HL; Gong HY; Ling LJ; Wang S; Li CY; Zong M
    Br J Radiol; 2021 Feb; 94(1118):20200874. PubMed ID: 32976019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters.
    Zhu Q; Tannenbaum S; Kurtzman SH; DeFusco P; Ricci A; Vavadi H; Zhou F; Xu C; Merkulov A; Hegde P; Kane M; Wang L; Sabbath K
    Breast Cancer Res; 2018 Jun; 20(1):56. PubMed ID: 29898762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of androgen receptor with ultrasound, clinicopathological features and clinical outcomes in breast cancer.
    Zhang X; Cui H; Hu N; Han P; Fan W; Wang P; Zuo X; Zhao D; Huang H; Li S; Kong H; Peng F; Tian J; Zhang L
    Insights Imaging; 2023 Mar; 14(1):46. PubMed ID: 36929229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case-control study.
    Sui L; Yan Y; Jiang T; Ou D; Chen C; Lai M; Ni C; Zhu X; Wang L; Yang C; Li W; Yao J; Xu D
    Breast Cancer Res Treat; 2023 Nov; 202(1):45-55. PubMed ID: 37639063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting HER2 Status in Breast Cancer on Ultrasound Images Using Deep Learning Method.
    Xu Z; Yang Q; Li M; Gu J; Du C; Chen Y; Li B
    Front Oncol; 2022; 12():829041. PubMed ID: 35251999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer.
    Bitencourt AGV; Gibbs P; Rossi Saccarelli C; Daimiel I; Lo Gullo R; Fox MJ; Thakur S; Pinker K; Morris EA; Morrow M; Jochelson MS
    EBioMedicine; 2020 Nov; 61():103042. PubMed ID: 33039708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.